Sarampo: o desafio da erradicação

Yu, Ana Lúcia Frugis; Ciccone, Flávia Helena; Carvalhanas, Telma Regina M. P.
Temas em Saúde Coletiva ; 3: 13-15, 2005. tab, graf
Artigo em Português | Coleciona SUS, SESSP-CTDPROD, SES-SP, SESSP-ACVSES, SESSP-CVEPROD, SES-SP | ID: biblio-946298

Documentos relacionados

  1. 'I was terrified for my child': understanding the link between the Dengvaxia® controversy and the measles vaccine hesitancy in Pasay City, Philippines.
  2. [What you always wanted and ought to know about measles].
  3. Insufficient measles antibody protection in 6-month-old Malawian infants: Reconsider vaccination schedule?
  4. In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-Analysis.
  5. Measles in non-human primates.
  6. Measles Vaccination Elicits a Polyfunctional Antibody Response, Which Decays More Rapidly in Early Vaccinated Children.
  7. Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy.
  8. Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial.
  9. The Effect of a Second Dose of Measles Vaccine at 18 Months of Age on Nonaccidental Deaths and Hospital Admissions in Guinea-Bissau: Interim Analysis of a Randomized Controlled Trial.
  10. Is There a Correlate of Protection for Measles Vaccine?